1. Home
  2. FNWD vs UNCY Comparison

FNWD vs UNCY Comparison

Compare FNWD & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$43.84

Market Cap

147.7M

Sector

Finance

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.15

Market Cap

150.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
UNCY
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
150.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
FNWD
UNCY
Price
$43.84
$5.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$37.50
$25.67
AVG Volume (30 Days)
6.4K
680.7K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
N/A
$675,000.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
$582.86
P/E Ratio
$43.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$3.72
52 Week High
$45.90
$8.74

Technical Indicators

Market Signals
Indicator
FNWD
UNCY
Relative Strength Index (RSI) 57.70 47.30
Support Level $34.83 $4.81
Resistance Level $45.90 $5.86
Average True Range (ATR) 0.65 0.22
MACD -0.29 -0.01
Stochastic Oscillator 47.99 29.01

Price Performance

Historical Comparison
FNWD
UNCY

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: